Search Results - "Patel, Hassaan"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution

    Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution by Basha, Riyaz, Connelly, Sarah F., Sankpal, Umesh T., Nagaraju, Ganji Purnachandra, Patel, Hassaan, Vishwanatha, Jamboor K., Shelake, Sagar, Tabor-Simecka, Leslie, Shoji, Mamoru, Simecka, Jerry W., El-Rayes, Bassel

    Published in The Journal of nutritional biochemistry (01-05-2016)
    “…Combination of dietary/herbal spice curcumin (Cur) and COX inhibitors has been tested for improving therapeutic efficacy in pancreatic cancer (PC). The…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract 2467: Association of specificity protein 1 and survivin expression in medulloblastoma: Identifying effective therapeutic targets

    Abstract 2467: Association of specificity protein 1 and survivin expression in medulloblastoma: Identifying effective therapeutic targets by Sankpal, Umesh T., Eslin, Don, Bowman, W. Paul, Murray, Jeffrey C., Sanchez, Irene, Jones, Michelle, Shelake, Sagar, Hernandez, Yazmin, Wadwani, Anmol, Patel, Hassaan, Dudhia, Ashni, Basha, Riyaz M.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Medulloblastoma (MB) is an aggressive malignant brain tumor diagnosed mostly in children. MB is typically treated using a multimodal approach…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Abstract 4818: Tolfenamic acid and curcumin treatment induces pancreatic cancer cell growth inhibition via suppressing Sp1 expression, NF-kB translocation to nucleus

    Abstract 4818: Tolfenamic acid and curcumin treatment induces pancreatic cancer cell growth inhibition via suppressing Sp1 expression, NF-kB translocation to nucleus by Basha, Riyaz M., Connelly, Sarah F., Purnachandra, Ganji, Sankpal, Umesh T., Patel, Hassaan, Vishwanatha, Jamboor K., Shelake, Sagar, Tabor-Simecka1, Leslie, Shoji, Mamoru, Simecka, Jerry Simecka W., El-Rayes, Bassel

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Pancreatic cancer (PC) is an aggressive malignancy. The current treatment options have limited response in addressing poor prognosis and low survival…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Small molecule tolfenamic acid and dietary spice curcumin treatment enhances anti-proliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution

    Small molecule tolfenamic acid and dietary spice curcumin treatment enhances anti-proliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution by Basha, Riyaz, Connelly, Sarah F., Sankpal, Umesh T., Nagaraju, Ganji Purnachandra, Patel, Hassaan, Vishwanatha, Jamboor K., Shelake, Sagar, Tabor-Simecka, Leslie, Shoji, Mamoru, Simecka, Jerry W., El-Rayes, Bassel

    Published in The Journal of nutritional biochemistry (10-02-2016)
    “…Combination of dietary/herbal spice curcumin (Cur) and COX inhibitors has been tested for improving therapeutic efficacy in pancreatic cancer (PC). The…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: